The result showed that TERT was not expressed in normal bladder but overexpressed in bladder cancer with core promoter C228T mutation TERT [5]; survival data of CDA, SLC9A1 and SLC24A4 also showed that their expression levels were associated with 5-year survival significantly. Here, SLC24A4 is linked to urinary bladder carcinoma.